1. Home
  2. XBIO

XBIO

Xenetic Biosciences Inc.

Logo Xenetic Biosciences Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.

Founded: N/A Country:
United States
United States
Employees: N/A City: FRAMINGHAM
Market Cap: 6.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 5.8K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.71 EPS Growth: N/A
52 Week Low/High: $2.55 - $5.97 Next Earning Date: 05-09-2024
Revenue: $2,539,986 Revenue Growth: 48.80%
Revenue Growth (this year): 8.43% Revenue Growth (next year): -33.33%

Share on Social Networks: